医学
免疫疗法
免疫学
抗原
嵌合抗原受体
癌症研究
癌症
免疫系统
癌症免疫疗法
抗体
白血病
作者
Ting Zhou,Hao-Wei Wang
标识
DOI:10.1016/j.cll.2021.04.005
摘要
Immunotherapy marked a milestone in cancer treatment and has shown unprecedented efficacy in a variety of hematological malignancies. Downregulation or loss of target antigens is commonly seen after immunotherapy, which often causes diagnostic dilemma and represents a key mechanism that tumor escapes from immunotherapy. The awareness of phenotypic changes after targeted immunotherapy is important to avoid misdiagnosis. Further understanding of the mechanisms of antigen loss is paramount for the development of therapeutic approaches that can prevent or overcome antigen escape in future immunotherapy.
科研通智能强力驱动
Strongly Powered by AbleSci AI